Objective: To investigate the protective effects of epigallocatechin-3-gallate (EGCG), a major polyphenol source in green tea, against hepatic ischaemia-reperfusion injury in mice. Methods: The partial hepatic ischaemia-reperfusion injury model was created by employing the hanging-weight method in C57BL/6 male mice. EGCG (50 mg/kg) was administered via an intraperitoneal injection 45 min before performing the reperfusion. A number of markers of inflammation, oxidative stress, apoptosis and liver injury were measured after the ischaemiareperfusion injury had been induced. Results: The treatment groups were: sham-operated (Sham, n ¼ 10), hepatic ischaemiareperfusion injury (IR, n ¼ 10), and EGCG with ischaemia-reperfusion injury (EGCG-treated IR, n ¼ 10). Hepatic ischaemia-reperfusion injury increased the levels of biochemical and histological markers of liver injury, increased the levels of malondialdehyde, reduced the glutathione/oxidized glutathione ratio, increased the levels of oxidative stress and lipid peroxidation markers, decreased B-cell lymphoma 2 levels, and increased the levels of Bax, cytochrome c, cleaved caspase-3, and cleaved caspase-9. Pretreatment with EGCG ameliorated all of these changes. Conclusion: The antioxidant and antiapoptotic effects of EGCG protected against hepatic ischaemia-reperfusion injury in mice.
Introduction
Hepatic ischaemia-reperfusion injury is the major cause of liver injury, which is of clinical concern, especially following diverse hepatectomy and living donor liver transplantation. 1 Ischaemia-reperfusion injury, which involves complex inflammatory pathways, is a significant cause of liver damage and an important factor in a variety of diseases, injuries, and following transplantation surgery. 2, 3 As liver ischaemia ends and reperfusion begins, oxidative stress is one of the first changes to take place and it regulates an oxidative stress-mediated apoptosis signalling pathway. [4] [5] [6] Hepatic oxidative stress and inflammation are important factors involved in the development of acute hepatic injury. 7 Damage to DNA bases is usually caused by reactive oxygen species (ROS), which include hydroxyl, the superoxide anion, and hydrogen peroxide. 8, 9 All ROS respond to varying degrees at the initiation of reperfusion as reduced electron carrier molecules of hypoxic cells donate electrons to oxygen during reperfusion. 10 Therefore, effective therapeutic strategies for hepatic ischaemia-reperfusion injury are urgently needed. During the early period of reperfusion, damage is induced by signalling molecules, specifically proinflammatory chemokines and cytokines such as interleukin (IL)-6 and tumour necrosis factor (TNF)-a, whereas neutrophilmediated cytotoxicity is the main cause of hepatic injury during the late period. 11, 12 Epigallocatechin-3-gallate (EGCG) is the major polyphenol found in green tea. 13, 14 It has a defensive effect against chronic inflammation and other diseases due to its antioxidative effects. [15] [16] [17] [18] [19] Furthermore, EGCG has been shown to be an effective treatment for the high levels of fat, cholesterol, and alcohol uptake that induce chronic liver injury, liver fibrosis and fatty hepatic disease in murine models. [20] [21] [22] However, the protective role of EGCG on hepatic ischaemiareperfusion injury and the specific molecular mechanisms related to oxidative stress remain unclear. 23, 24 The aim of this current study was to investigate the protective effects of EGCG against hepatic ischaemia-reperfusion injury in mice. Additionally, the study sought to clarify the molecular signalling mechanisms involved in regulating liver ischaemia-reperfusion injury, particularly the mechanisms related to oxidative stresses signalling and apoptosis.
Materials and methods

Murine model of hepatic ischaemia-reperfusion injury
Six-week old male C57BL/6 male mice were purchased from Joongang Laboratory Animals (Seoul, Republic of Korea) and were housed under constant temperature (22) (23) C) and normal humidity (40-60%) with a 12 h/12 h light/dark cycle. Mice (body weight range 20-30 g) were supplied with standard chow diet and reverse osmosis purified water. After 4 weeks, the partial hepatic ischaemia-reperfusion injury model was created by employing the hangingweight method as described previously. 25 In the partial hepatic ischaemia-reperfusion injury model mice, approximately 70% of the liver including the left lobe was exposed to 45 min of hepatic ischaemia followed by 6 h of reperfusion. All animal surgery and experimental protocols were approved by and performed in accordance with the Republic of Korea and Asan Medical Centre Institution Animal Care and Use Committee Guidelines regarding the use of living animals (no. 2015-02-052).
Administration of EGCG
Epigallocatechin-3-gallate was diluted in saline according to the supplier's instructions (Sigma-Aldrich, St Louis, MO, USA). In order to determine the dose of EGCG to use in the hepatic ischaemia-reperfusion injury experiments, a pilot study was undertaken in which EGCG was administered at a range of doses (10 mg/kg, 20 mg/kg, 50 mg/kg, 80 mg/kg, and 100 mg/kg; n ¼ 8 for each group). Each dose of EGCG was administered intraperitoneally just before performing the partial hepatic ischaemia injury for 45 min. After 6 h of reperfusion, whole blood samples and the damaged livers were obtained from the mice. In order to produce serum, the whole blood samples were kept at room temperature (22) (23) C) for 30-60 min to enable coagulation and then centrifuged at 2000 g for 30 min at 4 C to separate the serum. The clear supernatant was collected and stored at À80 C until use. Liver histology, hepatic malondialdehyde (MDA), hepatic glutathione (GSH):oxidized GSH (GSSG) ratio, serum alanine aminotransferase (ALT) and serum aspartate aminotransferase (AST) were assessed and significant improvements in all results were not observed until the mice were pretreated with at least 50 mg/kg (data not shown). As this pilot study demonstrated that 50 mg/kg was the most efficient dose, 50 mg/kg EGCG was administered via an intraperitoneal injection 45 min before performing the reperfusion for the remainder of the hepatic ischaemia-reperfusion injury experiments. For the current study, the mice were separated into the following three groups: sham-operated group (n ¼ 10), hepatic ischaemia-reperfusion injury group (n ¼ 10), and EGCG with ischaemia-reperfusion injury group (n ¼ 10). All surgical procedures were performed on mice anaesthetized by intraperitoneal injection of Zoletil 50 (0.15 ml kg
À1
; Virbac SA, Carros, France) and Rompun (0.3 ml kg
; Bayer Korea, Ansan, Republic of Korea) mixture. The mice in the sham-operated group underwent anaesthesia, laparotomy and suturing only.
Lipid peroxidation and glutathione tests
The thiobarbituric acid levels for reactive substances in the hepatic tissues were measured at a wavelength of 532 nm to measure the MDA level, which is the last product of lipid peroxidation. All reagents and specimens were prepared according to the manufacturer's instructions for a lipid peroxidation (MDA) assay kit (catalogue no. ab118970; Abcam, Cambridge, UK) and the optical density was assessed using a Sunrise TM microplate reader (Tecan, Ma¨nnedorf, Switzerland). The GSH level was measured using yeast-GSH reductase, 2-nitrobenzoic acid and nicotinamide adenine dinucleotide phosphate, at a wavelength of 412 nm using the Sunrise TM microplate reader. The same protocol was employed to measure the level of GSSG in the presence of 2-vinypyridine; then, the GSH:GSSG ratio was calculated. All procedures were undertaken in accordance with the manufacturer's instructions for the glutathione assay kit (catalogue no. 703002; Cayman Chemical Company, Ann Arbor, MI, USA).
Liver function test
Whole blood samples were collected from the inferior vena cava of the mice and were kept at room temperature (22) (23) C) for 30-60 min to enable coagulation. Clotted blood specimens were centrifuged at 2000 g for 30 min at 4 C to separate the serum. The clear supernatant was collected and stored at
À80
C until use. The levels of AST and ALT were analysed using a Hitachi 7180 automated biochemistry analyser (Hitachi, Tokyo, Japan) according to the manufacturer's instructions.
Transcriptional analyses
Total RNA was isolated from 45-50 mg of murine liver tissue after 6 h of reperfusion using QIAzol lysis solution and then separated into its mRNA components following the manufacturer's instructions (QIAGEN Korea, Seoul, Republic of Korea). cDNA was generated from the mRNA using an iScript TM 
Liver histology
The hepatic tissue samples were harvested after 6 h of reperfusion. The samples were fixed in 4% paraformaldehyde (pH 7.4; Sigma-Aldrich) and then embedded in paraffin wax for 24 h. The paraffin blocks were cut into 3 mm-thick sections. Liver sections were deparaffinized with xylene, serially rehydrated in a series of graded ethanol (100% to 80%) and stained with Mayer's haematoxylin (Sigma-Aldrich) and eosin Y (Sigma-Aldrich) solutions. Then the sections were dehydrated with serial solutions of graded ethanol (80% to 100%) and xylene. The sections were mounted on coverslips with Histomount mounting solution (Life Technologies, Carlsbad, CA, USA). Morphological changes to the liver tissues were observed using a light microscope (Â200; Axioskop 2 plus with AxioCam; Carl Zeiss, Thornwood, NY, USA). The tissue sections were scored for liver injury using the Suzuki scoring method (0-4) in order to determine the severity of sinusoidal congestion, vacuolization of the cytoplasm, and parenchymal cell necrosis. 27 Up to eight sections for each liver sample were studied (n ¼ 5-8 for each condition) by a pathologist who was blind to the experimental group.
Statistical analyses
All statistical analyses were performed using GraphPad Prism 6.0 software for Windows XP (GraphPad Software, La Jolla, CA, USA). The liver injury scores from the histological analysis are presented as median and range. All other data are presented as the mean AE SD of five to eight animals per group. For the Western blot analyses, the experiments were repeated at least three times. Statistical analyses were performed using one-way analysis of variance followed by Bonferroni's multiple comparison test. A value of P < 0.05 was considered statistically significant.
Results
Mice with hepatic ischaemia-reperfusion injury (IR group) showed higher levels of markers of liver injury compared with age-, sex-and weight-matched mice that had been pretreated with 50 mg/kg EGCG (EGCGtreated IR group), including significantly increased serum AST and ALT levels (Figures 1a and 1b) (P < 0.05 for both comparisons), significantly increased mRNA transcript levels of inflammatory markers (IL-6, TNF-a and IL-1b; Figures 1c-1f) (P < 0.05 for all comparisons) and greater histological evidence of liver injury (Figures 1g and 1h) . Hepatic reperfusion injury (IR group) was associated with a significant reduction in the level of IL-10 compared with the EGCG-treated mice (EGCG-treated IR group) (P < 0.05).
To examine the levels of hepatic ischaemia-reperfusion injury in each experimental group, lipid peroxidation and GSH component tests were undertaken on the injured hepatic tissue samples. As shown in Figure 2a , the EGCG-treated mice (EGCG-treated IR group) had significantly higher MDA levels compared with the sham-operated group (Sham group) (P < 0.05). The MDA level in EGCG-treated mice (EGCG-treated IR group) was significantly reduced compared with that in mice with hepatic ischaemia-reperfusion injury (IR group) (P < 0.05). The GSH:GSSG ratio in the mice with ischaemia-reperfusion injury (IR group) was significantly lower compared with the ratio in the sham-operated mice (Sham group) and in the EGCG-treated mice (EGCG-treated IR group) (P < 0.05 for both comparisons) (Figure 2b) .
The results of the Western blot analyses of the protein levels of antioxidant enzymes are shown in Figure 3a . The levels of the oxidative stress markers were increased in the mice with hepatic ischaemia-reperfusion injury (IR group) compared with the shamoperated mice (Sham group) and the EGCG-treated mice (EGCG-treated IR group). The lipid peroxidation proteins were increased in the mice with hepatic ischaemia-reperfusion injury (IR group) compared with the sham-operated mice (Sham group) in an effort to overcome hepatic injury (Figure 3a) . In contrast, the levels of HNE, MDA, CBR1, and acrolein were decreased in the EGCG-treated mice with ischaemia-reperfusion injury (EGCGtreated IR group) compared with the mice with hepatic ischaemia-reperfusion injury (IR group). Similarly, the levels of ALDH and AR were higher in the mice with hepatic ischaemia-reperfusion injury (IR group) compared with the EGCG-treated mice with ischaemia-reperfusion injury (EGCGtreated IR group). The results of RT-PCR of the mRNA levels of five oxidative stress markers confirmed the findings of the Western blot analyses (Figure 3b) .
The results of the Western blot analyses of the protein levels of Bcl-2, an antiapoptotic protein, showed that it was significantly downregulated in the mice with ischaemia-reperfusion injury (IR group) compared with the sham-operated mice (Sham group) (P < 0.05) (Figures 4a and  4b) . The EGCG-treated mice (EGCG-treated IR group) had levels of Bcl-2 comparable with the sham-operated mice (Sham group) suggesting that they had less liver injury as a result of activating the antiapoptotic signalling pathway. The results of the Western blot analyses of the protein levels of the proapoptotic protein Bax showed that the mice with ischaemia-reperfusion injury (IR group) had significantly higher levels compared with the sham-operated mice (Sham group) and the EGCG-treated mice (EGCG-treated IR group) (P < 0.05 for both comparisons). Mice with ischaemia-reperfusion injury (IR group) had significantly upregulated levels of cleaved caspase-3 and cleaved caspase-9 compared with the sham-operated mice (Sham group) and the EGCG-treated mice (EGCG-treated IR group) (P < 0.05 for all comparisons) (Figures 4c and 4d) . Mice with ischaemia-reperfusion injury (IR group) had significantly upregulated levels of cytochrome c compared with the shamoperated mice (Sham group) and the EGCG-treated mice (EGCG-treated IR group) (P < 0.05 for both comparisons) (Figures 4e and 4f) . 
Discussion
The biological functions of EGCG have been studied previously, including its antiinflammatory, antioxidative stress, and tumour-suppressing effects. 28, 29 However, the most important function of EGCG is its antioxidant effect. 30 During ischaemiareperfusion injury, ROS are highly involved in the development of tissue damage. 31 In the early stage of ischaemia, the singlet O 2 concentration is consistent with a low oxygen supply and the PO 2 is low enough to keep the oxygen-dependent lipid peroxidation reactions occurring at undetectable rates. 32 Free radicals can also induce lipid peroxidation in the cell phospholipid bilayer, which can destroy the cytosol and other organelles. 5, 33 The severity of oxidative stress and cell damage depends on the duration of the ischaemia. 25, 34 Reperfusion increases the steady state concentration of singlet O 2 and decreases both the concentration of chain-breaker antioxidants and antioxidant enzymes with a slight decrease in the oxygen uptake by tissues. 32 Critically, the antioxidant functions of EGCG can reduce ischaemia-reperfusion injury via activating antioxidant protection signalling. 35 In addition, EGCG has been shown to be an effective treatment for chronic liver disease, liver fibrosis, hepatic inflammation, alcoholinduced liver disease, and fatty liver. 7, [36] [37] [38] Despite this body of evidence and to the best of our knowledge, the potential protective roles of EGCG against hepatic ischaemiareperfusion injury has not been investigated previously.
In the present study, hepatic ischaemiareperfusion injury in a mouse model was characterized by the upregulation of the proinflammatory cytokines IL-6, IL-1b, and TNF-a. In contrast, levels of the antiinflammatory cytokine IL-10 were significantly decreased following hepatic ischaemia-reperfusion injury. Administration of EGCG reduced the levels of the proinflammatory cytokines and increased the level of IL-10. In this current study, EGCG treatment effectively reduced the markers of hepatic ischaemia-reperfusion injury, namely the GSH:GSSG ratio, showing that EGCG protects against oxidative stress by decreasing GSH following hepatic ischaemia-reperfusion injury. EGCG administration also reduced the amount of lipid peroxidation following hepatic ischaemiareperfusion injury. As these current data demonstrated, the upregulation of the oxidative stress markers, including HO-1, TRXr-1, NOS-2, Hsp70, and Hsp60, played an important role in protecting the liver from oxidative stress-induced damage. These upregulated oxidative enzymes are able to protect against hepatic ischaemiareperfusion injury by regulating oxidative stresses and free radical reactions. 39 These current data also showed that mice treated with EGCG had increased levels of antioxidant enzymes (i.e. HO-1 and TRXr-1) following hepatic ischaemia-reperfusion injury. The increase in the serum levels of AST and ALT was a strong indicator of the occurrence of oxidative stress damage in mice following hepatic ischaemia-reperfusion injury. Thus, the current findings suggest that the administration of EGCG reduces the oxidative stress damage that occurs following hepatic ischaemia-reperfusion injury.
Oxidative stress has been shown to regulate the apoptotic signalling pathway in cells. 40 Research has shown that many factors are associated with oxidative stressrelated cellular destruction, including members of the Bcl-2 family, [41] [42] [43] poly (ADP-ribose) polymerase (PARP), 44, 45 cleaved capase-3, 46 and cytochrome c. 47, 48 In particular, within the Bcl-2 family are antiapoptotic molecules that inhibit Ca 2þ release from the endoplasmic reticulum, 49 and lipid peroxidation from free radicals. 42 In contrast, Bax, another Bcl-2 family member, initiates cellular apoptosis through mitochondrial-related apoptosis. 50 Together, Bcl-2 and B-cell lymphoma extra large (BclxL) can create a heterodimer that can repress the proapoptotic function of Bax. 51, 52 Physiologically, equal amounts of the Bcl-2 and Bax proteins exist in the cell. 53 The present study hypothesized that EGCG administration would reduce hepatic ischaemia-reperfusion injury via Bcl-2-dependent mechanisms. Hepatic ischaemia-reperfusion injury in mice resulted in a downregulation of Bcl-2 protein levels and an upregulation of Bax protein levels in the present study. These effects were reduced following the administration of EGCG. In addition, PARP, caspase-3, and caspase-9 have been shown to be important cellular molecules involved in apoptotic signaling. 54, 55 Increases in PARP, caspase-3 and caspase-9 have been shown in other cells and the induction of caspase-3 and caspase-9 has been demonstrated in hepatic ischaemia-reperfusion injury, indicating that caspase-related cellular apoptosis signalling is harmful in ischaemia-reperfusion induced tissue damage. 56 In the present study, the levels of cleaved caspase-3 and cleaved caspase-9 protein increased in response to ischaemia-reperfusion injury and EGCG administration significantly reduced the levels of these two caspases. These present data suggest that EGCG administration reduces hepatic ischaemia-reperfusion-related cell apoptosis, possibly by decreasing cleaved caspase-3 and cleaved caspase-9 levels. Thus, the levels of cleaved caspase-3, cleaved caspase-9, and Bcl-2 proteins appear to be restored to normal levels by administering EGCG.
Proapoptotic proteins from the mitochondria result in mitochondrial membrane collapse, membrane depolarization, and the release of proapoptotic proteins from the mitochondria into the cytoplasm. 57 Therefore, the release of mitochondrial cytochrome c activates a signalling cascade for apoptosis. In the current study, the level of cytochrome c in the cytosol was upregulated by hepatic ischaemia-reperfusion injury and EGCG treatment decreased the hepatic ischaemia-reperfusion-induced increases in cytochrome c.
In summary, this present study demonstrated that EGCG treatment reduced the extent of hepatic ischaemia-reperfusion injury by decreasing oxidative stress-induced damage and cellular apoptosis. Hence, EGCG has the potential be used as a therapeutic agent for hepatic ischaemia-reperfusion injury.
